by David Kent | Aug 27, 2014
This post originally appeared on The Black Hole blog and is reprinted with permission from the author and University Affairs. I hate to admit this, but I find an incredible number of scientific papers really boring. It seems that more and more, research papers are...
by Stacey Johnson | Aug 22, 2014
. You have to be living under a rock – or perhaps spending every minute of your time culturing your cells – to be unaware of the ALS #Icebucketchallenge. Since it began on July 29 on social media, the American ALS Association has raised millions (nearly $42 million at...
by Sara M. Nolte | Aug 19, 2014
> In previous posts, I have alluded to the fact that studying cancer in a dish (in vitro) is not optimal (here and here). Today, I give you the next essential tool in a cancer stem cell (CSC) researcher’s toolbox: xenotransplantation. Xenotransplantation is an...
by Mark Curtis | Aug 18, 2014
. Welcome to your Update from the Clinic for the month of July. The cancer stem cell companies were back in the news last month. OncoMed initiated its ALPINE clinical trial of Tarextumab for pancreatic cancer, while Stemline Therapeutics announced an investigational...
by Lisa Willemse | Aug 15, 2014
I’m starting this post with an image that more or less sums up my life over the past two weeks, which has been rather intensely focused on creativity. This was the second time I traveled to Banff to be part of the Science Communications program at the Banff...
by Mark Curtis | Aug 11, 2014
. Welcome to your deal review for the month of July. There was financing activity this past month as StemCells and Fate Therapeutics each secured $20 million in funding. Bluebird bio was busy with the acquisition of a privately-held genome editing company; clearly a...
by Erin Sugar | Aug 8, 2014
. The following scene from Family Guy offers a glimpse into both the tone and subject matter of this week’s Right Turn. Being an avid lover of superheroes, monsters and all things supernatural, the topic of healing and limb regeneration has always been a subject I...
by Holly Wobma | Aug 5, 2014
> Imagine you are about to interview someone, and rather than receiving a full reference letter, your candidate is described with but a single word. Do you think you’d get the whole picture? Of course you wouldn’t, but depending on the word chosen, you could make a...
by Stacey Johnson | Jul 29, 2014
On June 18, 2014, I walked into the enormous, blue lit plenary hall of the Vancouver Convention Centre excited to hear Canada’s own Janet Rossant give the opening remarks for ISSCR’s Presidential Symposium. I glanced up at the information screens and read, to...
by Stacey Johnson | Jul 25, 2014
. It’s nice to end the week on a happy note. For a company like CCRM that commercializes regenerative medicine products and therapies, the news that ViaCyte, a company based in San Diego, California, has applied to the FDA to start clinical trials for its Type 1...
Comments